These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6826026)

  • 1. Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins.
    Hofbauer KG; Dienemann H; Forgiarini P; Stalder R; Wood JM
    Gen Pharmacol; 1983; 14(1):145-7. PubMed ID: 6826026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins.
    Cooper CL; Malik KU
    Br J Pharmacol; 1984 Jul; 82(3):679-88. PubMed ID: 6589024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II and bradykinin: interactions between two centrally active peptides.
    Lewis RE; Hoffman WE; Phillips MI
    Am J Physiol; 1983 Feb; 244(2):R285-91. PubMed ID: 6337513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the decreased renal blood flow in the potassium-depleted conscious rat.
    Linas SL; Dickmann D
    Kidney Int; 1982 May; 21(5):757-64. PubMed ID: 6180215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
    Pucci ML; Lin L; Nasjletti A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and renal medullary blood flow in Lyon rats.
    Sarkis A; Liu KL; Lo M; Benzoni D
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F365-72. PubMed ID: 12529274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension.
    Bivol LM; Vågnes OB; Iversen BM
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F393-400. PubMed ID: 15784843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
    Barrett RJ; Droppleman DA
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic response of PG synthesis to peptide hormones and osmolality in renal tubular cells.
    Wuthrich RP; Loup R; Favre L; Vallotton MB
    Am J Physiol; 1986 May; 250(5 Pt 2):F790-7. PubMed ID: 3085519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase.
    Cavarape A; Bauer J; Bartoli E; Endlich K; Parekh N
    Nephrol Dial Transplant; 2003 Sep; 18(9):1764-9. PubMed ID: 12937222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of bradykinin in rats.
    Dienemann H; Wood JM; Kraetz J; Stalder R; Hofbauer KG
    Adv Exp Med Biol; 1983; 156():651-60. PubMed ID: 6858758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the cat.
    Chapnick BM; Paustian PW; Feigen LP; Joiner PD; Hyman AL; Kadowitz PJ
    Circ Res; 1977 Apr; 40(4):348-54. PubMed ID: 403030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.
    Gardiner SM; Compton AM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Jan; 102(1):65-72. PubMed ID: 2043932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that bradykinin stimulates renal prostaglandin synthesis by a mechanism distinct from that of other vasoactive substances.
    Cooper CL; Malik KU
    Circ Res; 1987 Jun; 60(6):914-22. PubMed ID: 3109763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different vascular responses to subpressor angiotensin II administration in the mesenteric and renal circulation of rats.
    Cserep G; Abraham G; Tolins JP; Simon G
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):385-92. PubMed ID: 8722441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoregulatory hormones and the hyperfiltration of diabetes.
    Bank N; Lahorra MA; Aynedjian HS; Schlondorff D
    Am J Physiol; 1988 Feb; 254(2 Pt 2):F202-9. PubMed ID: 2449821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.